Given the frequency of variants identified in MAPT, GRN and C9ORF72, but also in our previous analysis of PSEN1, PSEN2 and APP, in the Turkish cohort of dementia patients studied, a standardized molecular screening procedure for these genes should be implemented in Turkey. The gene discussed is APP; the disease is dementia.